Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXQ3WM
|
||||
Drug Name |
4-(3-Allyl-4-oxo-3,4,5,6,7,8-hexahydro-benzo[4,5]thieno[2,3-d]pyrimidin-2-ylsulfanyl)-N-(4-sulfamoyl-phenyl)-butyramide
|
||||
Synonyms |
CHEMBL2018209
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H26N4O4S3
|
||||
Canonical SMILES |
NS(=O)(=O)c1ccc(NC(=O)CCCSC2=Nc3sc4CCCCc4c3C(=O)N2CC=C)cc1
|
||||
InChI |
InChI=1S/C23H26N4O4S3/c1-2-13-27-22(29)20-17-6-3-4-7-18(17)33-21(20)26-23(27)32-14-5-8-19(28)25-15-9-11-16(12-10-15)34(24,30)31/h2,9-12H,1,3-8,13-14H2,(H,25,28)(H2,24,30,31)
|
||||
InChIKey |
LIYILWMRHKDYMQ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase II | Target Info | [1587926] | ||
Carbonic anhydrase IX | Target Info | [1587926] | |||
NetPath Pathway | IL4 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Pathway Interaction Database | HIF-1-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.